Wednesday 12 March 2014

Nanotechnology Drug Delivery Market - 2013 - 2019

Nanotechnology has opened a new path for drug delivery to specific cells with the usage of nanoparticles. Nanomedical approach for drug delivery is centered on the development of nanoscale molecules or particles to improve the drug efficiency. Drugs are loaded on nanoparticles or nanocarriers (size is between 1 and 100 nm) and then transported in to the targeted site. Nanoparticles are engineered in such a manner that they are attracted to the diseased cells and then allow direct treatment of those cells. Using nanotechnology drug delivery the overall drug consumption and side effects can be lowered significantly. The highly selective approach reduces the side effects and cost as well. The new methods of nano technology are being developed for the treatment of serious illness such as cancer.

Browse the full report with request TOC at http://www.transparencymarketresearch.com/nanotechnology-drug-delivery.html

The targeted drug delivery for the treatment of cancer is one of the most anticipated benefits of nanotechnology enabled medicine. The targeted therapy offer high accuracy that further surpasses the present available methods. The lack of specificity of currently available drug delivery method destroys healthy cells along with the diseased cells. Moreover, 90% of the drug is wasted in the body that leads to unwanted side effects. Hence, owing to the comparative benefits of nanotechnology drug delivery over traditional methods is witnessing a significant growth. Moreover, growth in the market is also driven due to low research and development cost. The global nanotechnology drug delivery market is segmented on the basis of different types of nanoparticles. Different type of nanoparticles segment comprises lipid-based nanocarriers, organic nanocarriers, inorganic nanocarriers and polymer based nanocarriers.

Currently, a paradigm shift is being observed in the healthcare industry towards personalized medicines that is further increasing the demand for nanomedicines. However, treatment through nanoparticles in not new, Abraxane was the first product that was launched for treatment of breast cancer. Presently, there are now hundreds of nanoparticulate drug delivery products available.

Some of the key players in this industry are Celgene Corporation, Alkermes PLC., Novartis AG, among others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America
Asia Pacific
Europe
Rest of the World  

This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments

0 comments:

Post a Comment